Gainers & Losers
Wed Feb 11 2026 09:59:59- State Bank of India share price
- ₹1,182.003.31%
- Maruti Suzuki India share price
- ₹15,425.501.79%
- Tata Motors Passenger Vehi...
- ₹384.301.33%
- Trent share price
- ₹4,226.000.99%
- Reliance Industries share price
- ₹1,468.500.68%
Active Stocks
Wed Feb 11 2026 02:20:01- Tata Steel share price
- ₹207.65-0.14%
- Suzlon Energy share price
- ₹47.37-0.73%
- Yes Bank share price
- ₹21.33-0.33%
- Samvardhana Motherson Inte...
- ₹130.150.54%
- ICICI Bank share price
- ₹1,405.900.03%
Business News/Market/Market Stats/Procter & Gamble Health share price/ Procter & Gamble Health Profit Loss Annual
Procter & Gamble Health Profit & Loss Annual
5,487.00 +10.45 (0.19%)Updated : 11 Feb 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Jun 24 | Jun 23 | Jun 22 |
| Total Operating Expense | 632.47 | 892.85 | 933.04 | 873.27 |
| Other Net | 3.31 | 3.63 | 3.01 | 3.31 |
| Diluted Weighted Average Shares | 1.66 | 1.66 | 1.66 | 1.66 |
| Depreciation/ Amortization | 16.30 | 27.05 | 27.76 | 26.73 |
| Operating Income | 301.70 | 258.41 | 296.58 | 241.14 |
| Net Income | 234.41 | 200.98 | 229.47 | 192.52 |
| Income Availableto Com Excl Extra Ord | 234.41 | 200.98 | 229.47 | 192.52 |
| Other Operating Expenses Total | 4.73 | 16.09 | 16.63 | 9.96 |
| Net Income Before Taxes | 311.62 | 273.32 | 314.20 | 253.37 |
| Interest Exp( Inc) Net- Operating Total | 0.39 | 0.35 | 0.34 | 0.35 |
| Net Income After Taxes | 234.41 | 200.98 | 229.47 | 192.52 |
| Income Availableto Com Incl Extra Ord | 234.41 | 200.98 | 229.47 | 192.52 |
| Costof Revenue Total | 317.51 | 408.72 | 447.18 | 425.57 |
| Gross Profit | 616.66 | 742.54 | 782.44 | 688.84 |
| Interest Inc( Exp) Net- Non- Op Total | 6.61 | 11.28 | 13.90 | 9.46 |
| Unusual Expense( Income) | 2.11 | 22.89 | 11.93 | 5.91 |
| Diluted Net Income | 234.41 | 200.98 | 229.47 | 192.52 |
| DPS- Common Stock Primary Issue | 125.00 | 110.00 | 95.00 | 52.50 |
| Provisionfor Income Taxes | 77.21 | 72.34 | 84.73 | 60.85 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 234.41 | 200.98 | 229.47 | 192.52 |
| Total Revenue | 934.17 | 1,151.26 | 1,229.62 | 1,114.41 |
| period Length | 9.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 934.17 | 1,151.26 | 1,229.62 | 1,114.41 |
| Selling/ General/ Admin Expenses Total | 288.82 | 413.89 | 423.49 | 398.20 |
| Diluted Normalized EPS | 141.95 | 131.22 | 143.18 | 118.93 |
| Research Development | 2.61 | 3.86 | 5.71 | 6.55 |
| Diluted EPS Excluding Extra Ord Items | 141.00 | 121.08 | 138.24 | 115.98 |
| Gain( Loss)on Saleof Assets | - | 0.00 | 0.71 | -0.54 |
*All figures in crores except per share values
Procter & Gamble Health Quick Links
Procter & Gamble Health Dividend Procter & Gamble Health Bonus Procter & Gamble Health News Procter & Gamble Health AGM Procter & Gamble Health Rights Procter & Gamble Health Splits Procter & Gamble Health Board Meetings Procter & Gamble Health Key Metrics Procter & Gamble Health Shareholdings Procter & Gamble Health Balance Sheet Procter & Gamble Health Cashflow Procter & Gamble Health Q1 Results Procter & Gamble Health Q2 Results Procter & Gamble Health Q3 Results Procter & Gamble Health Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
305.75+16.90(5.85%)
207.50+5.40(2.67%)
367.50+5.65(1.56%)
1,577.70-24.35 (-1.52%)
968.35-14.65 (-1.49%)